Vilas Ventures
VC Fund
Fort Lauderdale, United States
Vilas Ventures is an investment firm that offers venture capital.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries Vilas Ventures invests in
Stages Vilas Ventures invests in
Countries Vilas Ventures invests in
Investment Focus
Industry
- Biotechnology 2 (67%)
- Software 1 (33%)
- Health Care 1 (33%)
- Life Science 1 (33%)
- Medical Device 1 (33%)
Stage
- Series A 1 (33%)
- Series C 1 (33%)
- Private Equity 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CND Life Sciences
|
CND Life Sciences develops an accurate, evidence-based tool that helps confirm a diagnosis of synucleinopathy. CND launched the Syn-One Test, a commercially available test to detect, visualize, and quantify the presence of abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. The test serves as an objective diagnostic tool to aid inthe confirmation of synucleinopathy in patients with suspected Parkinson’s disease (PD), dementia with Lewy body (DLB), multiple system atrophy (MSA), or pure autonomic failure (PAF).CND has research collaborations with multiple biopharmaceutical companies and is committed to advancing science in the field. | Private Equity / Aug 04, 2026 | |
|
CND Life Sciences
|
CND Life Sciences develops an accurate, evidence-based tool that helps confirm a diagnosis of synucleinopathy. CND launched the Syn-One Test, a commercially available test to detect, visualize, and quantify the presence of abnormal, phosphorylated alpha-synuclein in cutaneous nerve fibers. The test serves as an objective diagnostic tool to aid inthe confirmation of synucleinopathy in patients with suspected Parkinson’s disease (PD), dementia with Lewy body (DLB), multiple system atrophy (MSA), or pure autonomic failure (PAF).CND has research collaborations with multiple biopharmaceutical companies and is committed to advancing science in the field. | $13.5M / Series A / May 01, 2025 | |
Cortechs.ai
|
Cortechs.ai is a developer of brain image analysis software used to offer better clinical insight through quantitative imaging. It develops and markets cutting-edge brain imaging solutions that are used by neurologists and radiologists in hundreds of clinics and research centers around the world. Its software acts as a convenient and cost-effectivemeans to quantify brain structures that enable doctors in their assessment of a variety of neurological conditions, such as Alzheimer's disease, multiple sclerosis, epilepsy, and traumatic brain injury. | Series C / Nov 20, 2024 |
Co-Investors
Cambrian Capital Partners
1 deal together
Genting Berhad
1 deal together
HonorHealth
1 deal together
LabCorp
1 deal together
Lupo Labs
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Vilas Ventures invest in?
Vilas Ventures invests primarily in Biotechnology, Software and Health Care startups, most often at Series A and Series C stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Vilas Ventures last invest?
The most recent investment recorded for Vilas Ventures closed in Aug 2026. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
